REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 166 filers reported holding REVANCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,353,976 | -58.9% | 118,045 | -9.2% | 0.00% | -100.0% |
| Q2 2023 | $3,290,932 | -51.6% | 130,025 | -38.5% | 0.00% | -66.7% |
| Q1 2023 | $6,805,619 | +4.5% | 211,289 | -40.1% | 0.00% | 0.0% |
| Q4 2022 | $6,513,150 | +191.5% | 352,825 | +326.3% | 0.00% | +200.0% |
| Q3 2022 | $2,234,000 | +86.0% | 82,762 | -4.8% | 0.00% | – |
| Q2 2022 | $1,201,000 | -31.0% | 86,909 | -2.6% | 0.00% | -100.0% |
| Q1 2022 | $1,741,000 | +26.1% | 89,270 | +5.5% | 0.00% | – |
| Q4 2021 | $1,381,000 | -19.1% | 84,655 | +38.1% | 0.00% | -100.0% |
| Q3 2021 | $1,707,000 | +8.3% | 61,281 | +15.2% | 0.00% | 0.0% |
| Q2 2021 | $1,576,000 | +4.2% | 53,182 | -1.8% | 0.00% | 0.0% |
| Q1 2021 | $1,513,000 | +11.2% | 54,134 | +12.8% | 0.00% | – |
| Q4 2020 | $1,360,000 | +11.6% | 47,994 | -1.1% | 0.00% | – |
| Q3 2020 | $1,219,000 | -6.1% | 48,505 | -8.7% | 0.00% | -100.0% |
| Q2 2020 | $1,298,000 | +115.3% | 53,153 | +30.5% | 0.00% | – |
| Q1 2020 | $603,000 | -43.4% | 40,726 | -38.0% | 0.00% | – |
| Q4 2019 | $1,065,000 | +5816.7% | 65,650 | +4589.3% | 0.00% | – |
| Q3 2019 | $18,000 | 0.0% | 1,400 | 0.0% | 0.00% | – |
| Q2 2019 | $18,000 | -5.3% | 1,400 | +15.1% | 0.00% | – |
| Q1 2019 | $19,000 | +111.1% | 1,216 | +171.4% | 0.00% | – |
| Q4 2018 | $9,000 | -82.7% | 448 | -78.3% | 0.00% | – |
| Q3 2018 | $52,000 | -45.3% | 2,065 | -40.1% | 0.00% | – |
| Q2 2018 | $95,000 | +18.8% | 3,448 | +32.9% | 0.00% | – |
| Q1 2018 | $80,000 | -5.9% | 2,594 | +9.0% | 0.00% | – |
| Q4 2017 | $85,000 | +32.8% | 2,380 | +2.0% | 0.00% | – |
| Q3 2017 | $64,000 | +392.3% | 2,334 | +356.8% | 0.00% | – |
| Q2 2017 | $13,000 | – | 511 | +4545.5% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 11 | -99.0% | 0.00% | – |
| Q4 2016 | $22,000 | -29.0% | 1,052 | -44.5% | 0.00% | – |
| Q3 2016 | $31,000 | +342.9% | 1,896 | +271.0% | 0.00% | – |
| Q2 2016 | $7,000 | -22.2% | 511 | 0.0% | 0.00% | – |
| Q1 2016 | $9,000 | -85.9% | 511 | -72.9% | 0.00% | – |
| Q4 2015 | $64,000 | +326.7% | 1,889 | +277.8% | 0.00% | – |
| Q3 2015 | $15,000 | -6.2% | 500 | 0.0% | 0.00% | – |
| Q2 2015 | $16,000 | +23.1% | 500 | -23.9% | 0.00% | – |
| Q1 2015 | $13,000 | -40.9% | 657 | -49.7% | 0.00% | – |
| Q4 2014 | $22,000 | – | 1,305 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |